Richard J. Bleicher

4.2k citations

112 papers · 3.0k indexed · 1 hit paper · h-index 26

Oncology top 2%
Cancer Research top 1%
Surgery top 5%
Pathology and Forensic Medicine top 2%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Elin R. Sigurdson Brian L. Egleston Karen Ruth Marcia Boraas Myles C. Cabot Yu‐Ning Wong Eric A. Ross Leland J. Foshag
Topics: Breast Cancer Treatment Studies (76 papers)Global Cancer Incidence and Screening (33 papers)Breast Lesions and Carcinomas (33 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
Partner nations: United States Iran Greece

In The Last Decade

Richard J. Bleicher

98 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Time to Surgery and Breast Cancer Survival in the United States

2015 429 citations Richard J. Bleicher, Karen Ruth et al. profile →

Peers

Countries citing papers authored by Richard J. Bleicher

Since Specialization

Citations

This map shows the geographic impact of Richard J. Bleicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Bleicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Bleicher more than expected).

Fields of papers citing papers by Richard J. Bleicher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Bleicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Bleicher. The network helps show where Richard J. Bleicher may publish in the future.

Co-authorship network of co-authors of Richard J. Bleicher

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Bleicher. A scholar is included among the top collaborators of Richard J. Bleicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Bleicher. Richard J. Bleicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic? 2025 ·Breast Cancer Research and Treatment ·(unknown),(unknown),Joseph Cotler,D. C. Thompson,Richard J. Bleicher,Scott H. Kurtzman,(unknown),Katharine Yao	1
2	Time From Screening to Treatment at Accredited Breast Centers in the United States 2024 ·JCO Oncology Practice ·D. C. Thompson,(unknown),(unknown),Paul L. Baron,Toan T. Nguyen,Kathryn H. Schmitz,Jill R. Dietz,Richard J. Bleicher,Kristine Kuchta,(unknown),Katharine Yao	2
3	Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node‐Positive HR+, HER2− Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta‐Analysis 2024 ·The Breast Journal ·(unknown),(unknown),Austin D. Williams,(unknown),Richard J. Bleicher,(unknown),(unknown),Ramesh Omranipour,(unknown),(unknown),Mehran Habibi	0
4	ASO Visual Abstract: The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast Conserving Surgery—A Matched Pair Analysis 2023 ·Annals of Surgical Oncology ·(unknown),(unknown),(unknown),(unknown),Karen Ruth,Andrea S. Porpiglia,(unknown),Eric A. Ross,Elin R. Sigurdson,Richard J. Bleicher	1
5	The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast-Conserving Surgery: A Matched-Pair Analysis 2023 ·Annals of Surgical Oncology ·(unknown),(unknown),(unknown),(unknown),Karen Ruth,Andrea S. Porpiglia,(unknown),Eric A. Ross,Elin R. Sigurdson,Richard J. Bleicher	3
6	Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study 2023 ·The Breast ·(unknown),Carlos H. Bárcenas,Richard J. Bleicher,Adam L. Cohen,Sara H. Javid,Ellis Levine,Nancy U. Lin,Beverly Moy,Joyce C. Niland,Antonio C. Wolff,Michael J. Hassett,(unknown),Daniel G. Stover	0
7	Should patients with hormone receptor–positive, HER2–negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib? 2023 ·Cancer ·Austin D. Williams,Karen Ruth,(unknown),(unknown),(unknown),(unknown),Andrea S. Porpiglia,Richard J. Bleicher	9
8	Using pointwise mutual information for breast cancer health disparities research with SEER-Medicare claims 2023 ·Methodology ·Brian L. Egleston,(unknown),(unknown),Carolyn Y. Fang,Richard J. Bleicher,Slobodan Vučetić	2
9	Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer 2023 ·Cancer Reports ·Brian L. Egleston,Richard J. Bleicher,Carolyn Y. Fang,Thomas J. Galloway,Slobodan Vučetić	4
10	A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA 2022 ·Breast Cancer Research and Treatment ·(unknown),(unknown),Cecilia Chang,Chihsiung E. Wang,Elin R. Sigurdson,(unknown),Andrea S. Porpiglia,Maureen V. Hill,(unknown),Richard J. Bleicher	10
11	The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures 2021 ·Annals of Surgical Oncology ·Richard J. Bleicher,Meena S. Moran,Karen Ruth,Stephen B. Edge,(unknown),Lee G. Wilke,Vered Stearns,Scott H. Kurtzman,Jonah D. Klein,Katharine Yao	5
12	Statistical inference for natural language processing algorithms with a demonstration using type 2 diabetes prediction from electronic health record notes 2020 ·Biometrics ·Brian L. Egleston,(unknown),Richard J. Bleicher,(unknown),(unknown),Slobodan Vučetić	2
13	Breast Cancer Risk, Screening, and Prevalence Among Sexual Minority Women: An Analysis of the National Health Interview Survey 2020 ·LGBT Health ·Austin D. Williams,Richard J. Bleicher,Robin M. Ciocca	19
14	Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes 2019 ·Annals of Surgical Oncology ·(unknown),(unknown),Elias Obeid,J.M. Daly,Elin R. Sigurdson,Elizabeth A. Handorf,(unknown),(unknown),Richard J. Bleicher	33
15	Immediate breast reconstruction for women having inflammatory breast cancer in the United States 2018 ·Cancer Medicine ·Sameer A. Patel,Mingwei Ng,(unknown),Karen Ruth,Richard J. Bleicher	9
16	Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient 2016 ·Breast Cancer Research and Treatment ·Thomas M. Churilla,Brian L. Egleston,Colin T. Murphy,Elin R. Sigurdson,S.B. Hayes,Lori J. Goldstein,Richard J. Bleicher	20
17	History of Smoking is Associated with Younger Age at Diagnosis of Breast Cancer 2010 ·The Breast Journal ·Matthew C. Abramowitz,Tianyu Li,Monica Morrow,Penny R. Anderson,Richard J. Bleicher,Lori J. Goldstein,Ramona F. Swaby,(unknown),Gary M. Freedman	9
18	Young age is not associated with increased local recurrence for DCIS treated by breast‐conserving surgery and radiation 2009 ·Journal of Surgical Oncology ·Aruna Turaka,Gary M. Freedman,Tianyu Li,Penny R. Anderson,(unknown),Nicos Nicolaou,Lori J. Goldstein,Elin R. Sigurdson,Richard J. Bleicher	21
19	Skin‐sparing mastectomy 2003 ·Cancer ·Richard J. Bleicher,Nora Hansen,Armando E. Giuliano	26
20	Induction of glutathioneS-transferase π as a bioassay for the evaluation of potency of inhibitors of benzo(a)pyrene-induced cancer in a murine model 1997 ·International Journal of Cancer ·Xun Hu,(unknown),Sanjay Srivastava,Xia Hong,Richard J. Bleicher,Howard A. Zaren,Sanjay Awasthi,(unknown),Shivendra V. Singh	61

About Richard J. Bleicher

Richard J. Bleicher is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 112 papers that have together received 3.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (76 papers), Global Cancer Incidence and Screening (33 papers) and Breast Lesions and Carcinomas (33 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.6k citations) and Pathology and Forensic Medicine (507 citations). Richard J. Bleicher has collaborated with scholars based in United States, Iran and Greece. Frequent co-authors include Elin R. Sigurdson, Brian L. Egleston, Karen Ruth, Marcia Boraas, Myles C. Cabot, Yu‐Ning Wong, Eric A. Ross, Leland J. Foshag, Sameer A. Patel and Neal S. Topham. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact